You are here: Industry Insights > cancer

News List

FDA approves first targeted therapy for metastatic bladder cancer worldpharmanews
April 16, 2019
FDA approves first targeted therapy for metastatic bladder cancer.
High-dose vitamin D shows benefit in patients with advanced colorectal cancer worldpharmanews
April 16, 2019
High-dose vitamin D shows benefit in patients with advanced colorectal cancer...
The Classic “Miracle Drug” has “Fallen off the Miracle Path”? Still the “King” in the Cancer Prevention Field PharmaSources/Yefenghong
April 16, 2019
As one of the most commonly used and oldest drugs in the world, aspirin was originally synthesized by Bayer Company in 1897, and marketed two years later.
Pfizer to use Concerto HealthAI technology for cancer treatments pharmaceutical-technology
April 12, 2019
Pfizer has partnered with patient-centred research firm Concerto HealthAI to fast-track actionable patient insights for investigational and commercialised cancer therapies...
AstraZeneca and Daiichi Sankyo sign $6.9bn cancer drug development deal pharmaceutical-technology
April 11, 2019
AstraZeneca has entered a deal worth up to $6.9bn with Daiichi Sankyo to develop and commercialise cancer drug trastuzumab deruxtecan...
Researchers develop new vaccine to teach immune system to attack cancer pharmaceutical-technology
April 11, 2019
Researchers develop new vaccine to teach immune system to attack cancer.
BMS Opdivo/Yervoy recommended for untreated kidney cancer via Cancer Drugs Fund pharmafile
April 11, 2019
BMS Opdivo/Yervoy recommended for untreated kidney cancer via Cancer Drugs Fund.
Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer drugs
April 11, 2019
BOTHELL, Wash. and TOKYO, March 28, 2019 /PRNewswire/ -- Seattle Genetics, Inc.
Immune cells fighting blood cancer visualized for the first time worldpharmanews
April 10, 2019
When cancer escapes the immune system, our defenses are rendered powerless and are unable to fight against the disease...
NICE recommends BMS’ Opdivo-Yervoy combination for RCC pharmaceutical-technology
April 09, 2019
Bristol-Myers Squibb (BMS) has announced that the National Institute of Health and Care Excellence (NICE) has recommends Opdivo (nivolumab) and...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 88 89 Next page